{Reference Type}: Journal Article
{Title}: Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases.
{Author}: Santiago-Lamelas L;Dos Santos-Sobrín R;Carracedo Á;Castro-Santos P;Díaz-Peña R;
{Journal}: Best Pract Res Clin Rheumatol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 12
{Factor}: 4.991
{DOI}: 10.1016/j.berh.2024.101973
{Abstract}: Rheumatic diseases (RDs) are characterized by autoimmunity and autoinflammation and are recognized as complex due to the interplay of multiple genetic, environmental, and lifestyle factors in their pathogenesis. The rapid advancement of genome-wide association studies (GWASs) has enabled the identification of numerous single nucleotide polymorphisms (SNPs) associated with RD susceptibility. Based on these SNPs, polygenic risk scores (PRSs) have emerged as promising tools for quantifying genetic risk in this disease group. This chapter reviews the current status of PRSs in assessing the risk of RDs and discusses their potential to improve the accuracy of the diagnosis of these complex diseases through their ability to discriminate among different RDs. PRSs demonstrate a high discriminatory capacity for various RDs and show potential clinical utility. As GWASs continue to evolve, PRSs are expected to enable more precise risk stratification by integrating genetic, environmental, and lifestyle factors, thereby refining individual risk predictions and advancing disease management strategies.